Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Metabolic Disorders”

704 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 704 results

Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Early research (Phase 1)Temporarily pausedNCT01114750
What this trial is testing

Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)

Who this might be right for
Diabetes Mellitus
Bows Pharmaceuticals AG 8
Post-approval studies (Phase 4)UnknownNCT03987893
What this trial is testing

PEG3350 in ACLF With Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute-On-Chronic Liver Failure
Post Graduate Institute of Medical Education and Research, Chandigarh 60
Not applicableLooking for participantsNCT04096014
What this trial is testing

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
The Cleveland Clinic 40
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Not applicableStudy completedNCT04626570
What this trial is testing

Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid Obesity

Who this might be right for
ObesityFood Addiction
University Hospital, Tours 154
Not applicableNot Yet RecruitingNCT07334639
What this trial is testing

Metabolic Changes Associated With Weight Gain After Treatment of Achalasia

Who this might be right for
Achalasia, Esophageal
Assaf-Harofeh Medical Center 30
Early research (Phase 1)Study completedNCT07102095
What this trial is testing

A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose

Who this might be right for
Hepatic InsufficiencyLiver DiseasesPharmacokinetics+1 more
Bayer 18
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60
Post-approval studies (Phase 4)Looking for participantsNCT07521332
What this trial is testing

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Who this might be right for
CirrhosisEsophageal and Gastric VaricesAscites+3 more
Asian Institute Of Medical Sciences 220
Post-approval studies (Phase 4)Study completedNCT00375375
What this trial is testing

Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life

Who this might be right for
Minimal Hepatic EncephalopathyHepatic Encephalopathy
Post Graduate Institute of Medical Education and Research, Chandigarh 80
Large-scale testing (Phase 3)Study completedNCT01605136
What this trial is testing

Phase III Confirmatory Study in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 93
Testing effectiveness (Phase 2)Ended earlyNCT00068094
What this trial is testing

The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics

Who this might be right for
Fatty LiverHepatic SteatosisDiabetes Mellitus+1 more
National Center for Complementary and Integrative Health (NCCIH) 30
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Not applicableUnknownNCT05623930
What this trial is testing

Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty Liver

Who this might be right for
Fatty Liver
Cairo University 60
Testing effectiveness (Phase 2)Study completedNCT02949830
What this trial is testing

Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria
Alnylam Pharmaceuticals 16
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Early research (Phase 1)UnknownNCT05195125
What this trial is testing

Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients

Who this might be right for
End Stage Liver DIseaseObesityAcute Kidney Injury
University of Colorado, Denver 15
Testing effectiveness (Phase 2)Study completedNCT01429038
What this trial is testing

Mesenchymal Stem Cells After Renal or Liver Transplantation

Who this might be right for
Liver FailureKidney Failure
University of Liege 40
Large-scale testing (Phase 3)Ended earlyNCT00364689
What this trial is testing

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

Who this might be right for
Hepatic Encephalopathy
University of Miami 13
Next Page